It is my understanding that when you do an interim analysis of the clinical trial results, the enrollment needs to stop until the analysis is over and the DSMB makes a decision on clinical trial direction. Please correct me if i am wrong but i believe that this is the protocol. Nader keeps saying they are enrolling but the numbers are stagnant. Please correct me!